Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.440
+0.010 (0.41%)
At close: Feb 13, 2026
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €14.83 million as of February 13, 2026. Its market cap has increased by 1.88% in one year.
Market Cap
14.83M
Enterprise Value
11.90M
Revenue
23.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.44
Market Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 14.83M, a decrease of -61.03%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 14.83M | - |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.56B |
| Siemens Healthineers AG | 45.39B |
| Bayer Aktiengesellschaft | 45.18B |
| Fresenius SE & Co. KGaA | 28.53B |
| Cantourage Group SE | 51.25M |
| Pentixapharm Holding AG | 48.03M |
| MeVis Medical Solutions AG | 45.14M |
| aap Implantate AG | 21.14M |